Scientific partners
Collaborations
The objective of VHFMoDRAD is to develop and provide simple and rapid diagnostic tools for hemorrhagic fevers, and even other emerging viral diseases on the African continent.
This project started in 2019 and brings together 13 organizations, including RD-Biotech, which has put its skills in immunology and antibody engineering at the service of this project.
To propose an integrated offer from Gene to Viral Vectors
This strategic partnership’s objective is to propose a new and flexible end-to-end service, in order to enable our clients to accelerate the development of novel therapies and reach patients faster.
221025 -RD Biotech and ABL agreement – EN
Distributors
Distribution network for the fastELISA product range and for contract services e.g. development and production of antibodies, plasmids and recombinant proteins.
